Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus

Oct.26.2022
Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus
Advocates call for ban on flavored tobacco products in Columbus stores to address marketing targeting vulnerable communities.

Health advocates are urging the Columbus City Council to ban the sale of menthol cigarettes and flavored electronic cigarettes in stores throughout the city.


Amanda Turner, the Executive Director of Tobacco 21, stated that the city council has not yet proposed any legislation, but the proposal is currently being drafted. Turner explained that this issue first arose approximately 18 months ago during a conversation with the Columbus Department of Public Health.


Dr. Phillip Gardner, a public health expert, has stated that 85 cities in the United States have already banned the sale of menthol cigarettes and flavored e-cigarettes, with an additional 300 cities recently banning the sale of flavored e-cigarettes. Gardner, who is co-chair of the African American Tobacco Control Leadership Council, also noted that Canada has a nationwide ban on the sale of menthol cigarettes.


Gardner and Turner stated that prohibiting the sale of these products in the city will begin to reverse the effects of decades of marketing aimed specifically at black people, other people of color, women, LGBTQ individuals, and other marginalized groups. Gardner said that the industry profits by using "disproportionate marketing and predatory plunder" to exploit vulnerable communities and make a profit.


According to him, tobacco marketers have discovered that promoting menthol cigarettes to black celebrities and athletes, even lowering their costs in communities with African Americans. Currently, 85% of black smokers use menthol cigarettes, while the same figure for white smokers is 30%. "In the early 1950s, only 5% of African Americans smoked menthol cigarettes. By 1968, this percentage had almost tripled to 14%. By 1976, it had tripled again to 42%," Gardner said.


He stated that despite critics suggesting that such a ban would only create an illegal market or push shoppers to other jurisdictions, the data indicates that this has not been the case in these areas. Turner further explained that the data shows that removing more addictive tobacco from the equation would aid individuals in quitting smoking.


Many individuals may switch products, but research indicates that if you are using menthol cigarettes and wish to quit smoking and switch to regular cigarettes, your chances of successfully quitting are higher because menthol is a flavoring. It is a cooling agent that can suppress coughing, Turner explained.


Gardner stated that this is "outrageous" because adding menthol makes people more susceptible to nicotine addiction and more difficult to quit. "Menthol is defined as an anesthetic that actually covers up the harsh taste of tobacco smoke. It has a numbing and cooling effect and allows for deeper inhalation. The deeper you inhale, the more toxins and nicotine you ingest," Gardner said. "The more nicotine and toxins you ingest, the more addicted you become. Quitting becomes even harder. That's why they put it in there. It's outrageous from the start.


Gardiner stated that the FDA is currently exploring the idea of banning the use of menthol in cigarettes, but the process would take too long. "The FDA is considering getting rid of menthol, but unfortunately, due to the FDA's delay, it is important for communities like Columbus to take action themselves. The FDA will need several years to accomplish this," he said.


Turner and Gardner stated that the ban would not prohibit products within the city, but only the sale of them. Therefore, individuals would not face trouble for purchasing and bringing them in from elsewhere. "These laws are about getting retailers to stop selling them and not about individuals using personal property or pursuing a percentage," said Gardner.


Critics say the ban is unfair to smokers who enjoy menthol or use flavored e-cigarettes as an alternative to traditional cigarettes. Some argue that it discriminates against Black smokers. In response, Gardner stated that "racists are not public health doctors, they're in the tobacco industry." "Indeed, it has been the tobacco industry that has been discriminatory, that has been racist," Gardner continued. "It is not the tobacco control movement that is trying to save lives.


When asked why health officials are taking action to prevent flavored tobacco instead of flavored alcohol, Gardner explained that occasional alcohol consumption, not including binge drinking, does not kill people. However, "if you use cigarettes as expected, 50% of people will die from smoking.


Cigarettes are more deadly. In fact, tobacco-related diseases are the leading cause of death in the world, including in the United States, Ohio, and unfortunately Columbus. This is the reality. We are working hard to save lives," Gardner said.


Art Way, a drug policy consultant who works with the tobacco industry, argues that focusing on smoking cessation is a more effective way to reduce nicotine addiction. Targeted bans like these, Way contends, are similar to "patronizing, drug war-type policies that do not benefit our communities.


Statement:


This article is based on compiled third-party information and is only intended for intra-industry communication and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is solely for industry research and communication purposes.


Due to limitations in translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan or foreign-related expressions and perspectives.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21